Over the past 35 years, US age-adjusted mortality from cardiovascular disease declined by 50%, because of (1)new technologies to simplify diagnosis such as CT scan, and (2)generic drug and its multi-component agent such as polypill
Significantly reduce smoking rate, which increases relative risk significantly.